Aurora Investment Counsel’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-7,227
Closed -$782K 114
2018
Q1
$782K Sell
7,227
-9,135
-56% -$1.01M 0.39% 104
2017
Q4
$1.79M Buy
+16,362
New +$1.63M 0.89% 65
2014
Q4
$1.8M Buy
14,978
+4,639
+45% +$609K 1.11% 50
2014
Q3
$1.51M Sell
10,339
-15
-0.1% -$2.31K 0.99% 51
2014
Q2
$1.73M Buy
10,354
+238
+2% +$42.3K 1.09% 46
2014
Q1
$2.01M Buy
10,116
+35
+0.3% +$6.61K 1.29% 22
2013
Q4
$1.93M Sell
10,081
-1,719
-15% -$320K 1.27% 28
2013
Q3
$2M Sell
11,800
-116
-1% -$18K 1.45% 13
2013
Q2
$1.82M Buy
+11,916
New +$1.69M 1.42% 19

Other funds holding CLB

Aurora Investment Counsel's CLB Position: Q2 2018 in Review

Aurora Investment Counsel sold out of Core Laboratories (CLB) in Q2 2018, closing a stake of 7,227 shares — an estimated $782K sold.

Aurora Investment Counsel first reported a position in CLB in Q2 2013 and held it in 9 quarters. The position peaked at $2.01M in Q1 2014. 374 funds tracked by Wall St. Rank hold CLB as of Q2 2018.

  • Aurora Investment Counsel reported no remaining Core Laboratories position as of Q2 2018 after selling out during the quarter.
  • Aurora Investment Counsel sold 7,227 Core Laboratories shares in Q2 2018, an estimated $782K.
  • Aurora Investment Counsel first reported a position in Core Laboratories in Q2 2013 and held it in 9 quarters.
  • Aurora Investment Counsel's Core Laboratories position peaked at $2.01M in Q1 2014.
  • 374 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2018.

Based on Aurora Investment Counsel's 13F filing for Q2 2018, filed 25 Jul 2018.